Home / Research Library / Pharmaceutical pollution of the world’s rivers
🧬 Medicine & Biology OpenAlex

Pharmaceutical pollution of the world’s rivers

📅 February 14, 2022 👤 John L. Wilkinson, Alistair B.A. Boxall, Dana W. Kolpin et al. 📖 Proceedings of the National Academy of Sciences 📊 1,491 citations

🤖 Plain-English Summary

Environmental exposure to active pharmaceutical ingredients (APIs) can have negative effects on the health of ecosystems and humans. Concentrations of at least one API at 25.7% of the sampling sites were greater than concentrations considered safe for aquatic organisms, or which are of concern in terms of selection for antimicrobial resistance.

🔑 Key Findings

  • While numerous studies have monitored APIs in rivers, these employ different analytical methods, measure different APIs, and have ignored many of the countries of the world.
  • This makes it difficult to quantify the scale of the problem from a global perspective.
  • Additionally, comparison of the existing data, generated for different studies/regions/continents, is challenging due to the vast differences between the analytical methodologies employed.

💡 Why This Matters

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

Read the full paper
Access the original peer-reviewed research via OpenAlex.

View on DOI ↗

📋 Article Details

Category 🧬 Medicine & Biology
Published Feb 14, 2022
Journal Proceedings of the National Academy of Sciences
Authors John L. Wilkinson, Alistair B.A. Boxall, Dana W. Kolpin, Kmy Leung, Racliffe Weng Seng Lai
DOI 10.1073/pnas.2113947119
Citations 1,491
Source OpenAlex

More 🧬 Medicine & Biology Research